Search Results - Ethan Hsu
- Showing 1 - 8 results of 8
-
1
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance by Shonik Ganjoo, Nahum Puebla-Osorio, Selene Nanez, Ethan Hsu, Tiffany Voss, Hampartsoum Barsoumian, Lisa K. Duong, James W. Welsh, Maria Angelica Cortez
Published 2022-10-01
Article -
2
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention by Hampartsoum B. Barsoumian, PhD, Rahul A. Sheth, MD, Rishab Ramapriyan, BS, Ethan Hsu, BS, Mihai Gagea, DVM, Kaitlyn Crowley, BS, Duygu Sezen, MD, Malea Williams, BS, James W. Welsh, MD
Published 2023-03-01
Article -
3
Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy by Kewen He, Nahum Puebla-Osorio, Hampartsoum B. Barsoumian, Duygu Sezen, Zahid Rafq, Thomas S. Riad, Yun Hu, Ailing Huang, Tifany A. Voss, Claudia S. Kettlun Leyton, Lily Jae Schuda, Ethan Hsu, Joshua Heiber, Maria-Angelica Cortez, James W. Welsh
Published 2024-09-01
Article -
4
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy by Kewen He, Nahum Puebla-Osorio, Hampartsoum B. Barsoumian, Duygu Sezen, Zahid Rafiq, Thomas S. Riad, Yun Hu, Ailing Huang, Tiffany A. Voss, Claudia S. Kettlun Leyton, Lily Jae Schuda, Ethan Hsu, Joshua Heiber, Maria-Angelica Cortez, James W. Welsh
Published 2024-09-01
Article -
5
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases by Kewen He, Kewen He, Kewen He, Hampartsoum B. Barsoumian, Genevieve Bertolet, Vivek Verma, Carola Leuschner, Eugene J. Koay, Ethan B. Ludmir, Ethan Hsu, Esha Pisipati, Tiffany A. Voss, Nahum Puebla-Osorio, Maria Angelica Cortez, James W. Welsh
Published 2021-12-01
Article -
6
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model by Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B. Barsoumian, Qi Wang, Jordan Da Silva, Nalini B. Patel, Nguyen Nguyen, Denaha J. Doss, Ailing Huang, Ethan Hsu, Claudia S. Kettlun Leyton, Tiffany A. Voss, Fatemeh Masrorpour, Carola Leuschner, Jordan T. Pietz, Nahum Puebla-Osorio, Saumil Gandhi, Quynh-Nhu Nguyen, Jing Wang, Maria Angelica Cortez, James W. Welsh
Published 2022-11-01
Article -
7
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection by Yun Hu, Sébastien Paris, Narayan Sahoo, Genevieve Bertolet, Qi Wang, Qianxia Wang, Hampartsoum B. Barsoumian, Jordan Da Silva, Ailing Huang, Denaha J. Doss, David P. Pollock, Ethan Hsu, Nanez Selene, Claudia S. Kettlun Leyton, Tiffany A. Voss, Fatemeh Masrorpour, Shonik Ganjoo, Carola Leuschner, Jordan T. Pietz, Nahum Puebla-Osorio, Saumil Gandhi, Quynh-Nhu Nguyen, Jing Wang, Maria Angelica Cortez, James W. Welsh
Published 2023-06-01
Article -
8
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy by Nahum Puebla-Osorio, Natalie Wall Fowlkes, Hampartsoum B. Barsoumian, Kristina Xega, Gitika Srivastava, Claudia Kettlun-Leyton, Sara Nizzero, Tiffany Voss, Thomas S. Riad, Christina Wong, Ailing Huang, Yun Hu, Joylise Mitchell, Mingee Kim, Zahid Rafiq, Kewen He, Duygu Sezen, Ethan Hsu, Fatemeh Masrorpour, Aurian Maleki, Carola Leuschner, Maria Angelica Cortez, Philipp Oertle, Marko Loparic, Marija Plodinec, Janet L. Markman, James W. Welsh
Published 2024-10-01
Article